Skip to main content

Table 1 Comparison of gastric histology assessed according to Updated Sydney System scores among patients with diabetes and non-diabetes controls stratified by gender

From: Male non-insulin users with type 2 diabetes mellitus are predisposed to gastric corpus-predominant inflammation after H. pylori infection

Characters/mean(SD) or %(n) DM (n = 129) Non-DM (n = 129) P value DM vs. non-DM
Male (n = 73) Female (n = 56) P value male vs. female Male (n = 73) Female (n = 56) P value male vs. female
Age (years) 59.2 (11.0) 61.0 (10.2) 0.35 59.4 (11.2) 60.8 (10.3) 0.46
Non-ulcers gastritisa 53.4 (39) 62.5 (35) 0.30 26.0 (19) 69.6 (39) < 0.001 0.046
CISc Antrumb 2.85 (0.49) 2.95 (0.30) 0.18 2.81 (0.57) 2.77 (0.60) 0.60 0.13
Bodya 2.68 (0.62) 2.66 (0.72) 0.79 2.32 (0.85) 2.70 (0.57) 0.01 0.02
Cardia 2.40 (0.81) 2.30 (0.87) 0.58 2.12 (0.91) 2.46 (0.79) 0.03 0.45
AISc Antrum 1.84 (0.62) 2.02 (0.40) 0.08 1.71 (0.81) 1.77 (0.85) 0.58 0.13
Bodya 1.40 (0.95) 1.54 (0.89) 0.42 1.05 (1.03) 1.39 (0.95) 0.06 0.04
Cardia 1.16 (1.00) 0.86 (1.02) 0.09 0.90 (1.00) 1.16 (0.99 0.15 0.90
LFc Antrum 2.15 (2.11) 2.32 (2.01) 0.52 1.64 (1.87) 1.84 (1.87) 0.55 0.04
Bodya 1.49 (1.81) 1.29 (1.72) 0.48 0.66 (1.11) 0.70 (1.04) 0.70 0.001
Cardia 0.85 (1.53) 0.48 (0.89) 0.18 0.53 (0.96 0.48 (0.76) 0.96 0.74
HPDc Antrum 3.36 (1.31) 3.39 (1.30) 0.92 3.29 (1.64) 3.23 (1.41) 0.60 0.94
Body 3.21 (1.24) 3.36 (1.18) 0.42 3.16 (1.38) 3.41 (1.32) 0.32 0.77
Cardia 2.75 (1.38) 2.63 (1.27) 0.61 2.77 (1.51) 2.98 (1.42 0.46 0.24
IM Antrum 30.1 (22) 26.8 (15) 0.68 38.4 (28) 33.9 (18) 0.46 0.23
Body 15.1 (11) 17.9 (10) 0.67 15.1 (11) 10.7 (6) 0.47 0.48
Cardia 1.4 (1) 3.6 (2) 0.58 0 1.8 (1) 0.43 0.31
AT Antrum 67.1 (49) 67.9 (38) 0.93 68.5 (50) 62.5 (35) 0.48 0.79
Body 34.2 (25) 23.2 (13) 0.17 21.9 (16) 28.6 (16) 0.39 0.40
Cardia 17.8 (13) 14.3 (8) 0.62 12.3 (9) 8.9 (5) 0.54 0.19
  1. SD standard deviation, CIS chronic inflammation score, AIS acute inflammation score
  2. LF lymphoid follicle, HPD H. pylori density, IM intestinal metaplasia, AT atrophy
  3. DM Patients with diabetes, Non-DM patients without diabetes (controls)
  4. a: p < 0.05, male patients with and without DM
  5. b: p < 0.05, female patients with and without DM
  6. c: Mann-Whitney U test